3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Neoplasms
4
Lymphoma, Follicular
4
Lymphoma
4
Infections
4
Neoplasms, Plasma Cell
3
Lymphoma, Non-Hodgkin
3
Leukemia
3
Waldenstrom Macroglobulinemia
2
Thyroid Nodule
2
Sezary Syndrome
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neutropenia
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Intraocular Lymphoma
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Febrile Neutropenia
2
Burkitt Lymphoma
2
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Surgical Wound Infection
1
Sepsis
1
Interventions
Fluticasone-Salmeterol Drug Combination
3
Etanercept
3
Fluticasone
2
Budesonide
2
Beclomethasone
2
perflutren
1
laninamivir
1
fluticasone-formoterol
1
Sulfur Hexafluoride
1
Prednisolone
1
NVP-QAV680
1
Lysine Acetyltransferase 5
1
Health Information Exchange
1
Formoterol Fumarate
1
Exercise
1
Escitalopram
1
CS 8958
1
Budesonide, Formoterol Fumarate Drug Combination
1
Bronchial Thermoplasty
1
Blood Specimen Collection
1
Azithromycin
1
Amoxicillin-Potassium Clavulanate Combination
1
Albuterol
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Asthma
×
Amoxicillin-Potassium Clavulanate Combination
×
Clear all
NCT02517099
2023-03-06
PrIGMa
Imperial College London
Phase 2
Completed
60 enrolled
10 charts